While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...
Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...
Motif Neurotech announced today that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation ...
In the research world, Casey Harrell is known by subject name T-15. He's become a test case, and a point of hope, for people ...
Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation, brain-computer interface (BCI) ...
A research team has published details of a brain-computer interface that abandons the conventional approach of ...
Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A few weeks ago, a research paper out of MIT (the college) crossed my desk ...
Neuvotion announced today that it plans to launch its FDA-cleared NeuStim neurostimulation. technology later this year.
China is vigorously developing its BCI technology to solve clinical problems and drive economic growth. The country aims to cultivate the BCI sector, along with other industries of the future, into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results